ישראל - עברית - Ministry of Health

medison pharma ltd - edoxaban as tosylate - טבליות מצופות פילם - edoxaban as tosylate 15 mg - edoxaban

ישראל - עברית - Ministry of Health

medison pharma ltd - edoxaban as tosylate - טבליות מצופות פילם - edoxaban as tosylate 30 mg - edoxaban

ישראל - עברית - Ministry of Health

medison pharma ltd - edoxaban as tosylate - טבליות מצופות פילם - edoxaban as tosylate 60 mg - edoxaban

ישראל - עברית - Ministry of Health

gilead sciences israel ltd - lenacapavir as sodium - טבליות מצופות פילם - lenacapavir as sodium 300 mg - lenacapavir

ישראל - עברית - Ministry of Health

gilead sciences israel ltd - lenacapavir as sodium - תמיסה להזרקה - lenacapavir as sodium 309 mg/ml - lenacapavir

ישראל - עברית - Ministry of Health

sanofi israel ltd - enoxaparin sodium - תמיסה להזרקה - enoxaparin sodium 100 mg/ml ml - enoxaparin - enoxaparin - enoxaparin sodium is an anti-coagulant. at dosesof 20 mg and 40 mg it is indicated for: - prophylactic treatment of thrombo-embolic disorders of venous origin and in particular in orthopedic surgery or in general surgery. - prevention of thrombus formation in the extra-corporeal circulation during hemodialysis. at dosege of 40 mg the indications are: - prophylactic treatment of deep vein thrombosis in patients who are bedridden due to an acute medial disorder: - heart failure (hyha class iii or iv) - acute respiratory failure - episode of acute infection or acute rheumatic disorder combined with at least one other venous thromboembolic risk factor. at high doses of 60, 80 ,100 mg clexan is indicated for: -treatment of deep vein thrombosis (dvt). - treatment of unstable angina and non-q-wave myocardial infaction administered concurrently with aspirin. - treatment of pulmonary embolism.treatment of acute st- segment elevation myocardial infarction, in combination with a thrombolytic agent in patients eligible o

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - apixaban - טבליות מצופות פילם - apixaban 2.5 mg - apixaban - apixaban - prevention of venous thromboembolic events (vte) in adult patients who have undergone elective hip or knee replacement surgery.prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (nvaf), with one or more risk factors, such as prior stroke or transient ischaemic attack (tia); age? 75 years; hypertension; diabetes mellitus; symptomatic heart failure (nyha class ? ii).

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - apixaban - טבליות מצופות פילם - apixaban 5 mg - apixaban - apixaban - prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (nvaf), with one or more risk factors, such as prior stroke or transient ischaemic attack (tia); age? 75 years; hypertension; diabetes mellitus; symptomatic heart failure (nyha class ? ii).

ישראל - עברית - Ministry of Health

sanofi - aventis israel ltd - enoxaparin sodium - תמיסה להזרקה - enoxaparin sodium 150 mg/ml - enoxaparin - enoxaparin - for treatment of deep vein thrombosis (dvt) once daily. treatment of pulmonary embolism once daily.

ישראל - עברית - Ministry of Health

tzamal bio-pharma ltd - enoxaparin sodium - תמיסה להזרקה - enoxaparin sodium 100 mg / 1 ml - enoxaparin